Cargando…
Thrombolytic therapy at systemic lupus onset with secondary antiphospholipid syndrome: A rare stroke experience
Strokes are a major cause of disability in systemic lupus erythematosus (SLE). Classical neurological manifestations are rare at onset. The use of thrombolytic therapy improves clinical outcome in eligible stroke patients who present early. Modern imaging modalities augment decision making. This 37-...
Autores principales: | Loharia, Juned J., Alam, Junaid M., Abdelhadi, Hassan A., Marei, Tamer F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Riyadh : Armed Forces Hospital
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727608/ https://www.ncbi.nlm.nih.gov/pubmed/25630783 |
Ejemplares similares
-
Thrombolytic Therapy for Cerebral Vein Thrombosis in Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus
por: Hajialilo, Mehrzad, et al.
Publicado: (2012) -
Corticobasal Syndrome Associated with Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus
por: Hashimoto, Ritsuo, et al.
Publicado: (2018) -
Antiphospholipid syndrome in lupus retinopathy
por: Hong-Kee, Ng, et al.
Publicado: (2014) -
Review of Stroke Thrombolytics
por: Bivard, Andrew, et al.
Publicado: (2013) -
Libman-Sacks endocarditis in patients with systemic lupus erythematosus with secondary antiphospholipid syndrome
por: Mohammadi Kebar, Yousef, et al.
Publicado: (2019)